Amanote Research
Register
Sign In
Oral Tadalafil in Children With Pulmonary Arterial Hypertension
Drug Research
- Germany
doi 10.1055/s-0034-1395510
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Drug Discovery
Date
January 22, 2015
Authors
A. Shiva
M. Shiran
M. Rafati
H. Zamani
K. Babazadeh
M. Saeedi
S. Ala
Publisher
Georg Thieme Verlag KG
Related search
Tadalafil Therapy for Pulmonary Arterial Hypertension
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Pulmonary Arterial Hypertension in Children
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Ambrisentan and Tadalafil Up-Front Combination Therapy in Scleroderma-Associated Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Tadalafil: The Evidence for Its Clinical Potential in the Treatment of Pulmonary Arterial Hypertension
Core Evidence
Medicine
Reviews
References
Pharmacology
Pulmonary Arterial Hypertension
Current Problems in Cardiology
Medicine
Cardiovascular Medicine
Cardiology
Children With Pulmonary Arterial Hypertension and Prostanoid Therapy: Long-Term Hemodynamics
Journal of Heart and Lung Transplantation
Cardiology
Transplantation
Cardiovascular Medicine
Pulmonary
Respiratory Medicine
Surgery
Successful Titration of Triple Oral Therapy in a Patient With Pulmonary Arterial Hypertension (PAH)
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Pulmonary Arterial Hypertension Associated With Scleroderma
Advances in Pulmonary Hypertension
Role of Atrial Septostomy in the Treatment of Children With Pulmonary Arterial Hypertension
Heart
Cardiovascular Medicine
Cardiology